Compare StocksABBV vs GRMN

AbbVie Inc. (ABBV) vs Garmin Ltd. (GRMN): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. GRMN is overvalued at $294, with an intrinsic value of $202 and a margin of safety of -46%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
GRMN
Garmin Ltd.
$293.78

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
GRMN
  • Garmin Ltd. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 60.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Garmin Ltd. scores 91/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
GRMN
  • Despite buyback spending, shares outstanding increased in 3 out of 4 years — stock-based compensation is offsetting repurchases.
  • FCF yield of 2.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 30.3x is 37% above the historical average of 22.2x — the stock trades at a premium to its own history.

Key Valuation Metrics

Learn more →
ABBV
GRMN
Valuation
N/A
Free Cash Flow
$1.36B
N/A
FCF Yield
2.41%
70.89
Trailing P/E
30.32
15.41
Forward P/E
27.02
Quality & Moat
27.60%
ROIC
19.93%
N/A
ROE
21.89%
72.79%
Gross Margin
60.08%
0.41
PEG Ratio
3.62
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
-1.06
2.76%
Dividend Yield
1.43%
ABBV: 5Ties: 1GRMN: 2
ABBVGRMN

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

GRMN

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
GRMN
$8.32
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$2.57B
Δ Market Cap
+$21.39B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
GRMN
45.6% Overvalued
Price is 45.6% above estimated fair value
Current Price: $293.78
Fair Value: $201.84
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

GRMN

What growth rate is the market pricing in at $294?

+14.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +17.1%

The market implies +14.3% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +17.1%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
GRMN
91/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
GRMN
-2.26
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
GRMN
Insiders 14.7%Institutions 58.6%Retail & Other 26.8%
No. of Institutional Holders1,426
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
GRMN
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
GRMN
4
Sells (3M)
19
Sells (12M)
Total value (12M): $18.18M
HARTNETT JOSEPH J
Director
$169,476
@ $263.57 · 2026-06-09
HARTNETT JOSEPH J
Director
$151,806
@ $236.09 · 2026-06-09
BOESSEN DOUGLAS G
Chief Financial Officer
$475,812
@ $237.91 · 2026-06-05
MINARD LAURIE A
Officer
$262,365
@ $242.03 · 2026-05-08
LINK EDWARD J.
Officer
$310,647
@ $243.64 · 2026-03-10
BOESSEN DOUGLAS G
Chief Financial Officer
$877,541
@ $251.66 · 2026-02-26
PEMBLE CLIFTON A
Chief Executive Officer
$5.01M
@ $251.58 · 2026-02-26
DESBOIS PATRICK
Chief Operating Officer
$1.68M
@ $251.65 · 2026-02-26
MUNN MATTHEW W.
Officer
$1.32M
@ $250.97 · 2026-02-26
LYMAN SUSAN
Officer
$956,258
@ $251.32 · 2026-02-26
MINARD LAURIE A
Officer
$206,976
@ $247.28 · 2026-02-23
BIDDLECOMBE SEAN MICHAEL
Officer
$257,854
@ $240.76 · 2026-02-20
BOESSEN DOUGLAS G
Chief Financial Officer
$103,181
@ $215.41 · 2026-02-13
DESBOIS PATRICK
Chief Operating Officer
$773,868
@ $210.40 · 2026-01-07
BOESSEN DOUGLAS G
Chief Financial Officer
$512,562
@ $206.26 · 2025-12-16
PEMBLE CLIFTON A
Chief Executive Officer
$2.15M
@ $206.23 · 2025-12-16
WANG CHENG-WEI
Officer
$2.37M
@ $232.48 · 2025-08-27
LINK EDWARD J.
Officer
$395,140
@ $230.00 · 2025-08-11
MINARD LAURIE A
Officer
$181,010
@ $230.00 · 2025-08-06
BOESSEN DOUGLAS G
Chief Financial Officer
$399,685
@ $215.00 · 2025-07-03
PEMBLE CLIFTON A
Chief Executive Officer
$1.61M
@ $203.25 · 2025-06-16
LYMAN SUSAN
Officer
$609,677
@ $215.51 · 2025-03-10
BOESSEN DOUGLAS G
Chief Financial Officer
$625,969
@ $226.55 · 2025-02-28
MUNN MATTHEW W.
Officer
$1.04M
@ $225.31 · 2025-02-28
PEMBLE CLIFTON A
Chief Executive Officer
$1.64M
@ $227.14 · 2025-02-26
DESBOIS PATRICK
Chief Operating Officer
$1.57M
@ $227.15 · 2025-02-26
MINARD LAURIE A
Officer
$177,952
@ $226.11 · 2025-02-24
BOESSEN DOUGLAS G
Chief Financial Officer
$366,277
@ $207.99 · 2024-12-20
BOESSEN DOUGLAS G
Chief Financial Officer
$193,655
@ $216.62 · 2024-12-16
PEMBLE CLIFTON A
Chief Executive Officer
$2.20M
@ $216.58 · 2024-12-16
BIDDLECOMBE SEAN MICHAEL
Officer
$123,328
@ $210.10 · 2024-11-07
STRAUB PHILIP I
Officer
$499,023
@ $181.46 · 2024-08-30
MINARD LAURIE A
Officer
$15,815
@ $181.78 · 2024-08-28
WANG CHENG-WEI
Officer
$1.78M
@ $177.16 · 2024-08-21
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
GRMN
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
GRMN
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
View ABBV Full AnalysisView GRMN Full Analysis

Frequently Asked Questions: ABBV vs GRMN

Is AbbVie Inc. or Garmin Ltd. more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -40.7% margin of safety (intrinsic value $178 vs. price $251), compared to GRMN's -45.6% margin of safety (intrinsic $202 vs. $294).

Which stock has a wider economic moat, AbbVie Inc. or Garmin Ltd.?

GRMN scores 91/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. GRMN scores 14.2 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Garmin Ltd.?

ABBV earns 27.6% ROIC versus GRMN's 19.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Garmin Ltd.'s?

GRMN's dividend earns a safety score of 91/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). GRMN has raised its dividend for 2 consecutive years.

ABBV vs GRMN: Which Is the Better Buy in 2026? | SafetyMargin.io